ArticleBMC cardiovascular disorders2026
Prevalence and risk factors of atrial fibrillation in type 2 diabetes mellitus: a hospital-based cross-sectional study.
Article in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAtrial fibrillation (AF) is the most common sustained arrhythmia and is associated with adverse cardiovascular outcomes. In type 2 diabetes mellitus (T2DM), AF further increases the risk of heart failure, stroke, and premature death. However, epidemiological data in Asian populations remain limited. This study aimed to clarify the prevalence and identify risk factors of AF among patients with T2DM.
methodsWe conducted a hospital-based cross-sectional study using retrospectively collected medical records. AF was identified from physician documentation with electrocardiographic confirmation, including paroxysmal, persistent, and permanent types. Demographic, clinical, and laboratory variables were compared between AF and non-AF groups, and independent risk factors were assessed using multiple logistic regression.
resultsAmong 427 T2DM patients (mean age 63.6 ± 11.6 years), AF prevalence was 10.5%. Independent predictors of AF were older age (OR 1.06, 95% CI 1.02-1.11; p = 0.001), higher BMI (OR 1.07, 95% CI 1.01-1.13; p = 0.040), and heart failure (OR 4.39, 95% CI 1.56-12.39; p = 0.005). The predictive model incorporating these factors demonstrated fair discriminative ability (AUC 0.75, 95% CI 0.68-0.83).
conclusionsAF was present in one in ten T2DM patients. Older age, elevated BMI, and heart failure were independent predictors, and together provided moderate accuracy for AF risk prediction. These findings support targeted cardiovascular risk assessment and opportunistic AF screening in high-risk patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.